He was a Senior Staff Member and Director of the Renal Research Program in the Nephrology Division at Henry Ford Hospital, Detroit for 13 years then Director of R&D at Baxter Healthcare, Renal Division, for 11 years. In 2013 he founded BLR Bio an emerging biotechnology company focused on the diagnosis, prevention, and treatment of renal and other forms of fibrosis. The technology was created at Rosalind Franklin University of Medicine and Science in a laboratory effort he led over the last 12 years while also at Baxter. He holds an MS in Public Health and a PhD in cell/molecular biology both from the School of Public Health, and a Post-doctoral degree in Pathology from the Medical School, all at The University of Michigan He was a Senior Staff Member and Director of the Renal Research Program in the Nephrology Division at Henry Ford Hospital, Detroit for 13 years then Director of R&D at Baxter Healthcare, Renal Division, for 11 years. In 2013 he founded BLR Bio an emerging biotechnology company focused on the diagnosis, prevention, and treatment of renal and other forms of fibrosis. The technology was created at Rosalind Franklin University of Medicine and Science in a laboratory effort he led over the last 12 years while also at Baxter. He holds an MS in Public Health and a PhD in cell/molecular biology both from the School of Public Health, and a Post-doctoral degree in Pathology from the Medical School, all at The University of Michigan

Nephrology